Similar Papers

Paper Title
Journal
Date
Author
Abstract 108: Lipopolysaccharide Fails to Augment Development of Angiotensin II-induced Abdominal Aortic Aneurysms in Mice
Shayan Mohammadmoradi ... Deborah A Howatt
Arteriosclerosis, Thrombosis, and Vascular Biology | VOL. 38
Shayan Mohammadmoradi, et. al.Shayan Mohammadmoradi ... Deborah A Howatt
01 May 2018
Angiotensin I Infusion Reveals Differential Effects of Angiotensin-Converting Enzyme in Aortic Resident Cells on Aneurysm Formation.
Hisashi Sawada ... Xiaofeng Chen
Circulation journal : official journal of the Japanese Circulation Society | VOL. 84
Hisashi Sawada, et. al.Hisashi Sawada ... Xiaofeng Chen
24 Apr 2020
Dissecting abdominal aortic aneurysm in Ang II-infused mice: suprarenal branch ruptures and apparent luminal dilatation.
Bram Trachet ... Marco F M Stampanoni
Cardiovascular Research | VOL. 105
Bram Trachet, et. al.Bram Trachet ... Marco F M Stampanoni
23 Dec 2014
Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
Jing Liu ... Mary Sorci-Thomas
Arteriosclerosis, Thrombosis, and Vascular Biology | VOL. 35
Jing Liu, et. al.Jing Liu ... Mary Sorci-Thomas
04 Jun 2015
View more papers

More From: Cardiovascular Drugs and Therapy

Paper Title
Journal
Date
Author
The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights.
Maja Muric ... Vladimir Jakovljevic
Cardiovascular drugs and therapy | VOL. -
Maja Muric, et. al.Maja Muric ... Vladimir Jakovljevic
06 Feb 2025
Doxorubicin-Induced Cardiotoxicity: Can Andrographolide Provide a Silver Lining?
Mohit M Hulsurkar ... Xander H T Wehrens
Cardiovascular drugs and therapy | VOL. -
Mohit M Hulsurkar, et. al.Mohit M Hulsurkar ... Xander H T Wehrens
06 Feb 2025
Safety Analysis of Spironolactone Use in Patients Undergoing Percutaneous Coronary Intervention with High Bleeding Risk: A Propensity Score-Matched Study.
Junyan Zhang ... Yong He
Cardiovascular drugs and therapy | VOL. -
Junyan Zhang, et. al.Junyan Zhang ... Yong He
05 Feb 2025
Which Therapies Should Be Initiated After Optimizing Statins? A Multi-pillar Strategy for ASCVD Risk Reduction.
Olamide Oyenubi ... Xiaoming Jia
Cardiovascular drugs and therapy | VOL. -
Olamide Oyenubi, et. al.Olamide Oyenubi ... Xiaoming Jia
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.